Patterns of care for older patients with stage IV non‐small cell lung cancer in the immunotherapy era

od Kehl, Kenneth L., Hassett, Michael J., Schrag, Deborah
Izdano u Cancer Med (2020)

Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer

od Kehl, Kenneth L, Lathan, Christopher S, Johnson, Bruce E, Schrag, Deborah
Izdano u J Natl Cancer Inst (2018)

Assessment of Temporal Selection Bias in Genomic Testing in a Cohort of Patients With Cancer

od Kehl, Kenneth L., Schrag, Deborah, Hassett, Michael J., Uno, Hajime
Izdano u JAMA Netw Open (2020)

Insurance Networks and Access to Affordable Cancer Care

od Kehl, Kenneth L., Keating, Nancy L., Giordano, Sharon H., Schrag, Deborah
Izdano u J Clin Oncol (2020)

Access to Accredited Cancer Hospitals Within Federal Exchange Plans Under the Affordable Care Act

od Kehl, Kenneth L., Liao, Kai-Ping, Krause, Trudy M., Giordano, Sharon H.
Izdano u J Clin Oncol (2017)

Rates of BRCA1/2 mutation testing among young survivors of breast cancer

od Kehl, Kenneth L., Shen, Chan, Litton, Jennifer K., Arun, Banu, Giordano, Sharon H.
Izdano u Breast Cancer Res Treat (2015)

Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non–Small Cell Lung Cancer

od Kehl, Kenneth L., Greenwald, Scott, Chamoun, Nassib G., Manberg, Paul J., Schrag, Deborah
Izdano u JAMA Netw Open (2021)

Patient and proxy reports regarding the experience of treatment decision-making in cancer care

od Roydhouse, Jessica K., Gutman, Roee, Wilson, Ira B., Kehl, Kenneth L., Keating, Nancy L.
Izdano u Psychooncology (2020)

Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing among Patients with Newly Diagnosed Metastatic Lung Cancer

od Shen, Chan, Kehl, Kenneth L., Zhao, Bo, Simon, George R., Zhou, Shouhao, Giordano, Sharon H.
Izdano u Clin Lung Cancer (2016)

Oncologists' Experiences With Drug Shortages

od Kehl, Kenneth L., Gray, Stacy W., Kim, Benjamin, Kahn, Katherine L., Haggstrom, David, Roudier, Maryse, Keating, Nancy L.
Izdano u J Oncol Pract (2015)

Tumor Board Participation Among Physicians Caring for Patients With Lung or Colorectal Cancer

od Kehl, Kenneth L., Landrum, Mary Beth, Kahn, Katherine L., Gray, Stacy W., Chen, Aileen B., Keating, Nancy L.
Izdano u J Oncol Pract (2015)

Shared decision making in cancer care: The association of actual and preferred decision roles with patient-reported quality

od Kehl, Kenneth L., Landrum, Mary Beth, Arora, Neeraj K., Ganz, Patricia A., van Ryn, Michelle, Mack, Jennifer W., Keating, Nancy L.
Izdano u JAMA Oncol (2015)

Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist Notes

od Kehl, Kenneth L., Xu, Wenxin, Lepisto, Eva, Elmarakeby, Haitham, Hassett, Michael J., Van Allen, Eliezer M., Johnson, Bruce E., Schrag, Deborah
Izdano u JCO Clin Cancer Inform (2020)

Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports

od Kehl, Kenneth L., Elmarakeby, Haitham, Nishino, Mizuki, Van Allen, Eliezer M., Lepisto, Eva M., Hassett, Michael J., Johnson, Bruce E., Schrag, Deborah
Izdano u JAMA Oncol (2019)

Clinical Inflection Point Detection on the Basis of EHR Data to Identify Clinical Trial–Ready Patients With Cancer

od Kehl, Kenneth L., Groha, Stefan, Lepisto, Eva M., Elmarakeby, Haitham, Lindsay, James, Gusev, Alexander, Van Allen, Eliezer M., Hassett, Michael J., Schrag, Deborah
Izdano u JCO Clin Cancer Inform (2021)

Artificial intelligence in oncology: Path to implementation

od Chua, Isaac S., Gaziel‐Yablowitz, Michal, Korach, Zfania T., Kehl, Kenneth L., Levitan, Nathan A., Arriaga, Yull E., Jackson, Gretchen P., Bates, David W., Hassett, Michael
Izdano u Cancer Med (2021)

Discussions About Clinical Trials Among Patients With Newly Diagnosed Lung and Colorectal Cancer

od Kehl, Kenneth L., Arora, Neeraj K., Schrag, Deborah, Ayanian, John Z., Clauser, Steven B., Klabunde, Carrie N., Kahn, Katherine L., Fletcher, Robert H., Keating, Nancy L.
Izdano 2014

Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non–Small Cell Lung or Colorectal Cancer

od Kehl, Kenneth L., Riely, Gregory J., Lepisto, Eva M., Lavery, Jessica A., Warner, Jeremy L., LeNoue-Newton, Michele L., Sweeney, Shawn M., Rudolph, Julia E., Brown, Samantha, Yu, Celeste, Bedard, Philippe L., Schrag, Deborah, Panageas, Katherine S.
Izdano u JAMA Netw Open (2021)

Insurance clearance for early-phase oncology clinical trials following the Affordable Care Act

od Kehl, Kenneth L., Fullmer, Cheryl P., Fu, Siqing, George, Goldy C., Hess, Kenneth R., Janku, Filip, Karp, Daniel D., Kato, Shumei, Kizer, Cynthia K., Kurzrock, Razelle, Naing, Aung, Pant, Shubham, Piha-Paul, Sarina, Subbiah, Vivek, Tsimberidou, A.M., Hong, David S.
Izdano u Clin Cancer Res (2017)

Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis

od Lee, Yi, Clark, Evan W., Milan, Marina S.D., Champagne, Christine, Michael, Kesi S., Awad, Mark M., Barbie, David A., Cheng, Michael L., Kehl, Kenneth L., Marcoux, J. Paul, Rabin, Michael S., Rotow, Julia K., Sands, Jacob M., Jänne, Pasi A., Oxnard, Geoffrey R.
Izdano u JCO Precis Oncol (2020)